Nanobiotix (NBTX)

Currency in USD
21.82
+0.79(+3.76%)
Closed·
22.42+0.60(+2.75%)
·
NBTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
21.4222.05
52 wk Range
2.8230.35
Key Statistics
Prev. Close
21.03
Open
21.6
Day's Range
21.42-22.05
52 wk Range
2.82-30.35
Volume
27.53K
Average Volume (3m)
98.3K
1-Year Change
655.02%
Book Value / Share
-1.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NBTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.90
Downside
-31.70%
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Nanobiotix News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Nanobiotix Company Profile

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.

Compare NBTX to Peers and Sector

Metrics to compare
NBTX
Peers
Sector
Relationship
P/E Ratio
−17.4x−1.7x−0.6x
PEG Ratio
0.440.010.00
Price/Book
−13.0x1.6x2.6x
Price / LTM Sales
88.6x6.1x3.3x
Upside (Analyst Target)
−33.2%176.3%40.3%
Fair Value Upside
Unlock15.6%4.5%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 14.90
(-31.70% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Leerink Partners
Buy26.00+19.16%24.00MaintainNov 25, 2025
Leerink Partners
Buy24.00+9.99%14.00MaintainOct 01, 2025
Guggenheim
Buy8.00-63.34%12.00MaintainApr 04, 2025

Earnings

Latest Release
Nov 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NBTX Income Statement

People Also Watch

9.94
CRML
+20.05%
46.450
IREN
+5.66%
278.63
LEU
+3.93%
213.31
SNDK
+9.74%
18.66
NANOB
+4.71%

FAQ

What Is the Nanobiotix (NBTX) Premarket Price Today?

The Nanobiotix (NBTX) premarket price is 21.63. Premarket price change units: 0.37. Premarket percentage change: 1.74%. Premarket volume: 221.00. Current date: 05 Dec 2025. Previous close: 21.03

What Stock Exchange Does Nanobiotix Trade On?

Nanobiotix is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Nanobiotix?

The stock symbol for Nanobiotix is "NBTX."

What Is the Nanobiotix (NBTX) Afterhours Price Today? (Afterhours variable test: 22.42) Current Date: 05 Dec 2025

After hours price: 22.42. After hours price change (units): 0.60. Price change percentage: 2.75%

What Is the Nanobiotix Market Cap?

As of today, Nanobiotix market cap is 1.05B.

What Is Nanobiotix's Earnings Per Share (TTM)?

The Nanobiotix EPS (TTM) is -1.09.

When Is the Next Nanobiotix Earnings Date?

Nanobiotix will release its next earnings report on 27 Apr 2026.

From a Technical Analysis Perspective, Is NBTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Nanobiotix Stock Split?

Nanobiotix has split 0 times.

How Many Employees Does Nanobiotix Have?

Nanobiotix has 103 employees.

What is the current trading status of Nanobiotix (NBTX)?

As of 05 Dec 2025, Nanobiotix (NBTX) is trading at a price of 21.82, with a previous close of 21.03. The stock has fluctuated within a day range of 21.42 to 22.05, while its 52-week range spans from 2.82 to 30.35.

What Is Nanobiotix (NBTX) Price Target According to Analysts?

The average 12-month price target for Nanobiotix is USD14.90353229, with a high estimate of USD26.19958032 and a low estimate of USD3.88202378. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -31.70% Downside potential.

What Is the NBTX Premarket Price?

NBTX's last pre-market stock price is 21.63. The pre-market share volume is 221.00, and the stock has decreased by 0.37, or 1.74%.

What Is the NBTX After Hours Price?

NBTX's last after hours stock price is 22.42, the stock has decreased by 0.60, or 2.75%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.